Trace retroviral persistence and compare acquired immune damage with intrinsic immune defects.
NEET UG31 min study guide13 indexed sections
BY THE END, YOU CAN
Distinguish HIV infection, AIDS and the broader category of immunodeficiency.
Explain reverse transcription, integration and viral maturation at a conceptual level.
Interpret viral-load, cell-count and antibody evidence without confusing their targets.
Compare primary, secondary and combined immune defects using original reasoning cases.
BEFORE YOU START
Innate and adaptive immunity
DNA/RNA information flow
Autosomal recessive inheritance
Original educational lesson. Work through the examples before revealing the practice answers. Check the current official syllabus separately; historical question frequency does not establish eligibility or predict future questions.
CONNECT THE CONCEPT TO THE EXAM
Selected exam questions & worked solutions
These selected examples are separate from the original practice below. Each identifies its exam, year and wording. They do not represent every paper or every selected year.
No source-verified exam questions have been published for this lesson yet. The worked examples and practice below are original teaching material, not past-exam questions.
01 / UNDERSTAND & APPLY
1. A virus, an infection and a syndrome are different categories
HIV means human immunodeficiency virus. HIV infection means the virus has established infection in a person. AIDS means acquired immunodeficiency syndrome, an advanced stage defined by severe immune damage or particular associated conditions. The virus and the syndrome are not interchangeable names for the same biological object.
Without effective treatment, HIV can progressively impair important immune functions. Modern antiretroviral treatment can suppress viral replication and prevent progression, allowing people with HIV to live long, healthy lives. Older descriptions that imply inevitable rapid death after any HIV diagnosis are inaccurate.
HIV illustrates acquired immunodeficiency, but it does not cause every form of immunodeficiency. Genetic defects, some treatments, malnutrition and other conditions can compromise different immune components. The broader category must therefore be taught separately from this particular viral cause.
This is an educational lesson about mechanisms and evidence. It does not infer anyone’s status from symptoms, identity or behaviour, and it does not give testing intervals, drug regimens or individual exposure advice. Current personal decisions require appropriate clinical guidance.
02 / UNDERSTAND & APPLY
2. HIV carries RNA and enzymes but depends on host cells
HIV is an enveloped retrovirus. Its particle contains RNA genomes, structural proteins and enzymes important in its replication cycle, including reverse transcriptase, integrase and protease. An envelope is a membrane-derived covering with viral components involved in entry; it is not a bacterial cell wall.
Entry depends on suitable interactions with host receptors, prominently CD4 together with an appropriate co-receptor in the conventional model. CD4 helper T cells are major targets, and other susceptible cell types, including cells of the monocyte–macrophage lineage, can participate in infection and persistence.
The presence of viral RNA does not mean that HIV is a ribosome or that it carries all machinery required to reproduce independently. Viral protein production depends on host cellular processes. The name retrovirus refers to the RNA-to-DNA step within its replication strategy.
A host cell is not infected merely because any virus-shaped object touches any membrane. Receptor interactions, cellular context and subsequent intracellular events all matter. Target-cell specificity helps explain the consequences of infection for immune coordination.
03 / UNDERSTAND & APPLY
3. Follow the information through different molecular forms
After entry and appropriate uncoating-related events, reverse transcriptase produces a DNA form from the viral RNA template. This is reverse transcription. It is distinct from ordinary translation, which reads RNA to build a polypeptide, and from the later transcription of viral DNA into RNA.
Viral DNA can become integrated into host chromosomal DNA through the action of integrase. The integrated form is called a provirus. Integration does not mean that viral RNA itself has been inserted unchanged into the chromosome, nor does it make every cell of the person genetically identical to the infected cell.
From integrated viral DNA, host machinery can produce viral RNA. Some RNA serves as messenger RNA for protein synthesis, while genomic RNA can be packaged into new particles. Information therefore follows RNA → DNA → RNA, with RNA → protein through translation.
The molecular sequence explains why reverse transcriptase and integrase are different targets. Blocking RNA-to-DNA synthesis and blocking integration interrupt different transitions. This mechanistic comparison does not specify a clinical drug choice or a laboratory method for modifying the virus.
Full-size scientific diagram. Swipe or scroll horizontally; keyboard users can focus the diagram and use arrow keys.
Original high-level mechanism map, not to scale or a replication protocol. Placement of pre-integration stages is an information-flow layout, not an assertion that reverse transcription completes exclusively in the cytoplasm; nuclear completion can occur. Cell entry details, trafficking, splicing and many regulatory events are omitted. Protease-mediated polyprotein processing contributes to maturation; this diagram does not give sequences, operating conditions or treatment choices.
04 / UNDERSTAND & APPLY
4. Making a particle and making it functional are different steps
Viral components assemble, and new particles bud from the cell membrane. Protease-mediated processing of viral polyproteins is important in maturation. A newly assembled particle is not automatically equivalent to a fully mature infectious particle.
Antiretroviral medicines can act at different stages of this cycle. Their purpose is to suppress successful viral replication and preserve immune function. The existence of several targets does not mean that every medicine acts on every stage or that drug combinations can be chosen without clinical assessment.
Integrated viral genetic material can persist in long-lived cellular reservoirs, including cells not actively producing large amounts of virus at a particular moment. Suppressed plasma viral load therefore does not by itself establish that every infected cell or every proviral copy has been removed.
Clinical latency is also different from complete viral inactivity. A person can have few or no symptoms while infection persists. Conversely, effective suppression can substantially change the disease course; an untreated historical trajectory should not be used as a fixed timetable for someone receiving effective care.
05 / UNDERSTAND & APPLY
5. Loss of a coordinator affects several immune pathways
CD4 helper T cells participate in activation and coordination of other immune functions. Their signals support many antibody responses, macrophage activation and interactions with cytotoxic responses. Progressive damage to this network can therefore compromise more than one narrow defensive task.
HIV does not cause AIDS simply by removing every antibody from the blood. Antibodies can remain detectable, including antibodies used in diagnostic assays, while protective immune coordination is impaired. Presence of an immune response and successful control of infection are different observations.
Opportunistic infections become more likely when normally effective defence is compromised. The word opportunistic describes the relationship between an organism and a susceptible host; it does not imply that the organism is imaginary or that every encounter causes disease.
Certain cancers also become more frequent in settings of immune impairment. These associations reflect interacting mechanisms involving immune surveillance, infections and cell regulation. They should not be reduced to a claim that HIV directly transforms every affected tissue into a tumour.
06 / UNDERSTAND & APPLY
6. Viral load and immune-cell counts measure different things
Acute HIV infection can involve rapid viral replication and nonspecific symptoms, although symptoms alone cannot identify infection. A chronic phase can follow, with ongoing infection and variable clinical appearance. Advanced immune damage can lead to AIDS when defining criteria are met.
Viral load measures the amount of viral genetic material detected in a defined sample volume, commonly reported as RNA copies per millilitre of blood plasma. A CD4 count measures cells, commonly per microlitre of blood. The quantities have different units and cannot be compared by simply dividing the printed numbers as though they were the same measurement.
In the standard clinical classification context, a CD4 count below 200 cells per microlitre, equivalent to per cubic millimetre, is one AIDS-related criterion in adults and adolescents with HIV; specified defining conditions can also establish the classification. This is not a standalone rule for diagnosing HIV from any low cell count.
A falling viral load during effective treatment and improvement in immune measures can support biological response, but individual patterns vary. An illustrative graph can teach relationships without predicting an exact person’s timing, symptoms or long-term outcome.
07 / UNDERSTAND & APPLY
7. Transmission needs a biologically appropriate exposure route
HIV transmission involves particular body fluids and access to susceptible tissues or the bloodstream. Sexual exposure, sharing contaminated injection equipment, and transmission during pregnancy, birth or breastfeeding are recognised routes. Screening of blood supplies and appropriate infection-control systems address other exposure pathways.
Ordinary social contact such as sharing a classroom, hugging or using the same toilet does not transmit HIV. Mosquitoes do not serve as HIV vectors. HIV is not a respiratory infection spread through ordinary shared air, and someone’s appearance cannot establish whether they have HIV.
The fact that malaria uses a mosquito does not imply that any blood-associated virus can replicate in that insect and be transmitted through the same route. Vector competence is a biological relationship, not merely contact with blood.
Transmission risk can be changed substantially by prevention and effective treatment. People with HIV who achieve and maintain an undetectable viral load on effective treatment do not transmit HIV through sex, expressed as undetectable equals untransmittable in that context. That established statement should not be carelessly extended to every other route or treated as proof that infection has been eradicated.
08 / UNDERSTAND & APPLY
8. The assay target determines what a test can show
An antibody assay detects the host response to viral antigens. An antigen assay detects a viral component, and a nucleic-acid test detects viral genetic material. These are different targets that become detectable on different timelines after infection.
A window period is the interval in which an infection may not yet be detectable by a particular test. Its length depends on the test and context. A result obtained immediately after an exposure cannot be interpreted as a universal exclusion of infection without considering these limitations.
ELISA is a method based on antigen–antibody recognition and a linked detection system; it is not uniquely an HIV test. Historical educational material often mentions it in HIV diagnosis, but modern diagnostic algorithms combine appropriate assays and confirmation procedures. One generic positive screening signal is not a complete clinical diagnosis.
Detecting antibody does not mean the antibody has cleared the virus, and an undetectable plasma RNA result during treatment does not mean every provirus is absent. Clear reasoning starts by naming the material measured, the sample and the question the assay is meant to answer.
09 / UNDERSTAND & APPLY
9. Immunodeficiency can affect different parts of the network
Immunodeficiency means inadequate function of one or more immune components. It can involve antibody production, T-cell function, combined lymphocyte defects, phagocyte activity or complement. A normal result for one component cannot establish that every other component works normally.
Primary immunodeficiencies, increasingly discussed within inborn errors of immunity, arise from intrinsic defects often related to genetic variants. Secondary or acquired immunodeficiency arises in association with other conditions or exposures, including HIV infection, particular treatments or nutritional deficiency.
Primary does not mean symptoms must always be obvious at birth. Some conditions are recognised later, depending on severity, residual function and circumstances. Secondary does not mean mild or unimportant. The classification concerns origin, not a universal ranking of seriousness.
For example, a defect primarily affecting antibody quantity or quality can impair extracellular-target defence, while a phagocyte defect can impair uptake, recruitment or killing despite measurable antibodies. Complement deficiencies can affect opsonisation, lysis or immune-complex handling. These examples show why a single total white-cell count is not a complete functional evaluation.
Full-size scientific diagram. Swipe or scroll horizontally; keyboard users can focus the diagram and use arrow keys.
Original conceptual comparison, not a diagnostic decision tree. ADA deficiency is one cause of combined immunodeficiency, not the cause of all SCID. Primary defects can present at different ages, and acquired does not mean mild. No treatment selection follows directly from this map.
10 / UNDERSTAND & APPLY
10. A metabolic enzyme defect can disrupt immune development
Severe combined immunodeficiency, or SCID, describes a group of severe defects affecting adaptive immune development or function. Combined highlights impairment involving cellular immunity and effective humoral defence, rather than one fixed gene mutation shared by every case.
Adenosine deaminase deficiency is one cause. Reduced ADA activity can allow harmful purine-metabolism intermediates to accumulate, damaging developing lymphocytes. The causal chain links a genetic change to enzyme function, metabolite handling and loss of immune-cell development.
ADA deficiency is classically inherited in an autosomal recessive pattern. Under a simplified model with two carrier parents, each conception has a one-quarter probability of inheriting two affected alleles. This probability is a genetic model, not a prediction that exactly one child in every group of four must be affected.
Not all ADA deficiency has identical severity, and not all SCID is ADA deficiency. A cause can be an important example without defining the entire category. This distinction prevents a named textbook case from replacing a broader mechanistic classification.
11 / UNDERSTAND & APPLY
11. Deficiency, allergy and autoimmunity answer different questions
Allergy involves an inappropriate response to an otherwise often harmless exposure, while autoimmunity involves damaging responses against self components. Immunodeficiency concerns inadequate protective function. These categories can overlap in complex immune dysregulation, so a person need not fit one isolated box for every aspect of their condition.
Passive antibody support can supply selected effector molecules, but does not reconstruct every missing T-cell, phagocyte or complement function. Similarly, a vaccine depends on the recipient’s capacity to mount the required response; it cannot be assumed to repair any underlying immune defect.
Different medical approaches address different mechanisms, including suppressing a causative infection, replacing selected missing functions or correcting particular cellular defects. The lesson compares biological targets, not treatment eligibility or product choices.
Recurrent or unusual infection patterns can motivate professional investigation, but common infections also occur in people without immunodeficiency. Neither stigma nor a self-assigned label helps identify the mechanism. Sound evaluation combines history, appropriate tests and specialised interpretation.
12 / UNDERSTAND & APPLY
12. Worked mechanism and evidence cases
All numerical and classification cases are original teaching models, not personal clinical interpretations.
ORIGINAL WORKED EXAMPLE
Trace the information
Order HIV RNA, integrated viral DNA, newly transcribed RNA and viral protein within the simplified replication framework.
Reverse transcription makes a DNA form from viral RNA.
Integration places viral DNA within host DNA.
Transcription produces RNA, and translation of messenger RNA produces proteins.
Answer RNA → DNA/provirus → RNA → protein, with genomic RNA also available for packaging.
ORIGINAL WORKED EXAMPLE
Different enzymes, different transitions
A model inhibitor blocks integration but not reverse transcription. Can a DNA form still be produced before the blocked step?
Reverse transcription precedes integration in this model.
The inhibited enzyme controls insertion into host DNA, not RNA-to-DNA synthesis itself.
An earlier product can exist even when a later transition fails.
Answer Yes. Production of viral DNA and its integration are distinct events.
ORIGINAL WORKED EXAMPLE
Do not confuse quantities
A report gives viral RNA copies per mL and CD4 cells per µL. Are these two measurements of viral concentration?
One counts viral genetic-material copies in a sample volume.
The other counts a host immune-cell type.
Different numerator units identify different biological quantities.
Answer No. Viral load and CD4 count measure different things.
ORIGINAL WORKED EXAMPLE
A model fold reduction
A hypothetical viral-load measure falls from 80,000 to 800 copies/mL with the same assay. Find fold reduction and percentage decrease.
Divide initial by final: 80,000/800 = 100.
The decrease is 79,200 from an initial 80,000.
79,200/80,000 × 100 = 99%.
Answer 100-fold reduction and 99% decrease; this alone does not prove eradication.
ORIGINAL WORKED EXAMPLE
Classify the origin
Case A involves inherited lymphocyte-development failure; case B involves immune impairment after HIV infection. Classify the deficiency origins.
A begins with an intrinsic inherited developmental defect.
B is associated with an acquired infection.
The origin classification does not by itself rank severity.
Answer A primary/inborn; B secondary/acquired.
ORIGINAL WORKED EXAMPLE
Carrier-parent probability
Two carriers Aa × Aa have children under an autosomal recessive model. Find the probability of aa and the carrier probability among unaffected offspring.
Offspring genotype probabilities are 1/4 AA, 1/2 Aa and 1/4 aa.
Unaffected offspring comprise AA and Aa, total 3/4.
Conditional carrier probability is (1/2)/(3/4) = 2/3.
Answer Affected probability 1/4; carrier probability among unaffected offspring 2/3.
ORIGINAL WORKED EXAMPLE
Antibody support has limits
A model supplies preformed antibody to a recipient with a major T-cell functional defect. Does this reconstruct all missing cellular immunity?
The teaching notes, worked explanations and original practice are written for this lesson. Separately labeled selected exam questions identify their exam, year, source and whether wording is paraphrased or an exact excerpt. Educational references do not certify current exam coverage.
NCERT Biology, Class XII: Human Health and Disease (textbook reference)